Literature DB >> 19342370

SPARC accelerates disease progression in experimental crescentic glomerulonephritis.

Amy N Sussman1, Tong Sun, Ronald M Krofft, Raghu V Durvasula.   

Abstract

Podocytopenia characterizes many forms of glomerular disease, preceding the development of glomerulosclerosis. While detachment of viable podocytes from the underlying glomerular basement membrane is an important mechanism of podocyte loss, the underlying factors involved remain unclear. Secreted protein acidic and rich in cysteine (SPARC), a matricellular protein with counteradhesive properties, is normally expressed at low levels by the podocyte but is markedly increased following podocyte injury. Accordingly, we elucidate the role of SPARC in mediating experimental crescentic glomerulonephritis by inducing passive nephrotoxic nephritis in SPARC(+/+) and SPARC(-/-) mice. By days 4, 7, and 21 following disease induction, podocyte number is better preserved, glomerulosclerosis is ameliorated, and proteinuria is reduced in SPARC(-/-) mice as compared with SPARC(+/+) littermates. Moreover, the preserved podocyte number in SPARC(-/-) mice correlates with reduced urinary levels of both nephrin and podocin. To establish a causal role for SPARC in mediating detachment, cultured SPARC(+/+) and SPARC(-/-) podocytes were subjected to mechanical strain as well as trypsin digestion, and detachment assays were performed. While podocytes lacking SPARC were more resistant to stretch-induced detachment, stable re-expression of SPARC restored detachment rates to levels comparable with SPARC(+/+) podocytes. Taken together, this study proves that SPARC plays a causal role in mediating podocyte detachment and accelerating glomerulosclerosis in experimental crescentic glomerulonephritis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19342370      PMCID: PMC2671271          DOI: 10.2353/ajpath.2009.080464

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  49 in total

Review 1.  Extracellular proteins that modulate cell-matrix interactions. SPARC, tenascin, and thrombospondin.

Authors:  E H Sage; P Bornstein
Journal:  J Biol Chem       Date:  1991-08-15       Impact factor: 5.157

2.  Podocytopenia and disease severity in IgA nephropathy.

Authors:  Kevin V Lemley; Richard A Lafayette; Massy Safai; Geraldine Derby; Kristina Blouch; Addy Squarer; Bryan D Myers
Journal:  Kidney Int       Date:  2002-04       Impact factor: 10.612

3.  Mechanical stress reduces podocyte proliferation in vitro.

Authors:  Arndt T Petermann; Keiju Hiromura; Mary Blonski; Jeffrey Pippin; Toshi Monkawa; Raghu Durvasula; William G Couser; Stuart J Shankland
Journal:  Kidney Int       Date:  2002-01       Impact factor: 10.612

4.  Direct derivation of conditionally immortal cell lines from an H-2Kb-tsA58 transgenic mouse.

Authors:  P S Jat; M D Noble; P Ataliotis; Y Tanaka; N Yannoutsos; L Larsen; D Kioussis
Journal:  Proc Natl Acad Sci U S A       Date:  1991-06-15       Impact factor: 11.205

5.  Amelioration of diabetic nephropathy in SPARC-null mice.

Authors:  Sekiko Taneda; Jeffrey W Pippin; E Helene Sage; Kelly L Hudkins; Yasuo Takeuchi; William G Couser; Charles E Alpers
Journal:  J Am Soc Nephrol       Date:  2003-04       Impact factor: 10.121

Review 6.  A basis for accelerated progression of diabetic nephropathy in Pima Indians.

Authors:  Kevin V Lemley
Journal:  Kidney Int Suppl       Date:  2003-02       Impact factor: 10.545

7.  Distribution of the calcium-binding protein SPARC in tissues of embryonic and adult mice.

Authors:  H Sage; R B Vernon; J Decker; S Funk; M L Iruela-Arispe
Journal:  J Histochem Cytochem       Date:  1989-06       Impact factor: 2.479

8.  Podocytes that detach in experimental membranous nephropathy are viable.

Authors:  Arndt T Petermann; Ron Krofft; Mary Blonski; Keiju Hiromura; Michael Vaughn; Raimund Pichler; Sian Griffin; Takehiko Wada; Jeffrey Pippin; Raghu Durvasula; Stuart J Shankland
Journal:  Kidney Int       Date:  2003-10       Impact factor: 10.612

9.  Nephrinuria in diabetic nephropathy of type 1 diabetes.

Authors:  Anu Pätäri; Carol Forsblom; Marika Havana; Heidi Taipale; Per-Henrik Groop; Harry Holthöfer
Journal:  Diabetes       Date:  2003-12       Impact factor: 9.461

10.  Urinary excretion of viable podocytes in health and renal disease.

Authors:  Stefanie U Vogelmann; W James Nelson; Bryan D Myers; Kevin V Lemley
Journal:  Am J Physiol Renal Physiol       Date:  2003-03-11
View more
  5 in total

Review 1.  Role of biomechanical forces in hyperfiltration-mediated glomerular injury in congenital anomalies of the kidney and urinary tract.

Authors:  Tarak Srivastava; Ganesh Thiagarajan; Uri S Alon; Ram Sharma; Ashraf El-Meanawy; Ellen T McCarthy; Virginia J Savin; Mukut Sharma
Journal:  Nephrol Dial Transplant       Date:  2017-05-01       Impact factor: 5.992

2.  Mapping haplotype-haplotype interactions with adaptive LASSO.

Authors:  Ming Li; Roberto Romero; Wenjiang J Fu; Yuehua Cui
Journal:  BMC Genet       Date:  2010-08-27       Impact factor: 2.797

3.  The Function of SPARC as a Mediator of Fibrosis.

Authors:  Jessica Trombetta-Esilva; Amy D Bradshaw
Journal:  Open Rheumatol J       Date:  2012-06-15

4.  A novel in vivo method to quantify slit diaphragm protein abundance in murine proteinuric kidney disease.

Authors:  Raphael Haase; Sebastian Alexander Potthoff; Catherine Meyer-Schwesinger; Clara Frosch; Thorsten Wiech; Ulf Panzer; Eva Königshausen; Johannes Stegbauer; Lorenz Sellin; Lars Christian Rump; Ivo Quack; Magdalena Woznowski
Journal:  PLoS One       Date:  2017-06-12       Impact factor: 3.240

5.  End-stage renal disease is different from chronic kidney disease in upregulating ROS-modulated proinflammatory secretome in PBMCs - A novel multiple-hit model for disease progression.

Authors:  Ruijing Zhang; Jason Saredy; Ying Shao; Tian Yao; Lu Liu; Fatma Saaoud; William Y Yang; Yu Sun; Candice Johnson; Charles Drummer; Hangfei Fu; Yifan Lu; Keman Xu; Ming Liu; Jirong Wang; Elizabeth Cutler; Daohai Yu; Xiaohua Jiang; Yafeng Li; Rongshan Li; Lihua Wang; Eric T Choi; Hong Wang; Xiaofeng Yang
Journal:  Redox Biol       Date:  2020-02-20       Impact factor: 11.799

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.